Bridging the AI Divide in Drug Discovery: Practical Lessons from Capacity Strengthening in Africa
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Jason Hlozek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Cape Town, Western Cape7700, South Africa. Hauptthemen laut MEDLINE: Drug Discovery, Artificial Intelligence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci??n y Universidades, European Commission, Schmidt Sciences.
Abstract (Originalsprache)
Artificial Intelligence (AI) has become an integral part of drug discovery in high-income countries. However, these advances have yet to be broadly adopted by research ecosystems in many low- and middle-income countries in Africa, where understudied infectious diseases, compounded by a growing noncommunicable disease burden, cause millions of deaths each year. Given adequate support and appropriate models AI could play a transformative role in under-resourced biomedical research ecosystems in Africa, democratizing drug discovery research. There is an urgent need to invest in building the critical infrastructure, tools, and capacity required. To drive this agenda forward, Ersilia, the H3D Centre, and H3D Foundation with support from the AI2050 program at Schmidt Sciences hosted a series of in-person and online workshops in Africa to grow the AI skills base for medicinal chemistry and enable adoption across regional research hubs. In this perspective article, we discuss the lessons learnt from this program, the fit-for-purpose open-source tools developed, and key considerations for future initiatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Cape Town, Western Cape7700, South Africa.
- Ersilia Open Source Initiative , Barcelona08039, Spain.
- H3D Foundation, Cape Town, Western Cape7700, South Africa.
- South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, Western Cape7925…
ORCID-Profile: Miquel Duran-Frigola, Susan Winks, Gemma Turon, Kelly Chibale
Förderung
- Ministerio de Ciencia, Innovaci??n y Universidades
- European Commission
- Schmidt Sciences
Zitieren
APA
Hlozek, J., Duran-Frigola, M., Elliott-Wong, N., Stander, R., Winks, S., Turon, G., & Chibale, K. (2026). Bridging the AI Divide in Drug Discovery: Practical Lessons from Capacity Strengthening in Africa. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01429
Vancouver
Hlozek J, Duran-Frigola M, Elliott-Wong N, Stander R, Winks S, Turon G, et al. Bridging the AI Divide in Drug Discovery: Practical Lessons from Capacity Strengthening in Africa. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01429
BibTeX
@article{Hlozek2026,
author = {Hlozek, Jason and Duran-Frigola, Miquel and Elliott-Wong, Nicola and Stander, Rudolf and Winks, Susan and Turon, Gemma and Chibale, Kelly},
title = {Bridging the AI Divide in Drug Discovery: Practical Lessons from Capacity Strengthening in Africa},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01429}
}
EUVIMED